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ARTICLE
Chronic virus infection compromises memory
bystander T cell function in an IL-6/
STAT1-dependent manner
Isabel Barnstorf1, Mariana Borsa1*, Nicolas Baumann1*, Katharina Pallmer1*, Alexander Yermanos1, Nicole Joller2, Roman Spo¨rri1,
Suzanne P.M. Welten1, Nike J. Kra¨utler1, and Annette Oxenius1
Chronic viral infections are widespread among humans, with ∼8–12 chronic viral infections per individual, and there is
epidemiological proof that these impair heterologous immunity. We studied the impact of chronic LCMV infection on the
phenotype and function of memory bystander CD8+ T cells. Active chronic LCMV infection had a profound effect on total
numbers, phenotype, and function of memory bystander T cells in mice. The phenotypic changes included up-regulation of
markers commonly associated with effector and exhausted cells and were induced by IL-6 in a STAT1-dependent manner in the
context of chronic virus infection. Furthermore, bystander CD8 T cell functions were reduced with respect to their ability to
produce inﬂammatory cytokines and to undergo secondary expansion upon cognate antigen challenge with major cell-
extrinsic contributions responsible for the diminished memory potential of bystander CD8+ T cells. These ﬁndings open new
perspectives for immunity and vaccination during chronic viral infections.
Introduction
The immune responsiveness of a host toward microbial chal-
lenges or vaccines is given by the structural and cellular con-
stituents of the immune system, which are subject to transient
or permanent environmental modulations (Beura et al., 2016;
Reese et al., 2016). Such modulations are a result of the previous
infection and vaccination history of an individual, the constant
encounter with commensal microorganisms on mucosal surfa-
ces as well as the steady exposure to persistent viral infections.
Chronic viral infections are highly prevalent, with ∼8–12
chronic infections per individual (Virgin et al., 2009).
Chronic viral infections can be subdivided into those caused
by actively replicating virus, such as the infections caused by
HIV and hepatitis B and C viruses in humans or lymphocytic
choriomeningitis virus (LCMV) in the mouse, or latent/re-
activating infections like the ones caused by herpesviruses. Over
the past decades, substantial knowledge has been gained about
the regulation of virus-speciﬁc T and B cell immunity in these
types of persistent viral infections (Hangartner et al., 2006;
Doria-Rose and Connors, 2009; Frebel et al., 2010; Wherry,
2011). In case of actively replicating persistent infections,
virus-speciﬁc CD8+ T cell responses are generally compromised
in size and function (termed T cell exhaustion; Wherry and
Kurachi, 2015), while virus-speciﬁc CD4+ T cells seem to pref-
erentially differentiate into T follicular helper cells (Tfh; Fahey
et al., 2011; Harker et al., 2011; Cubas et al., 2013). In addition,
rapidly mutating viruses constantly change their recognition
motifs and challenge antibody and T cell responses by immune
evasion (Hangartner et al., 2006; Burton et al., 2012). In case of
latent/reactivating persistent viral infections, substantial im-
mune resources are devoted to the long-term control of viral
reactivation events, most prominently seen in CMV infection in
humans and mice. Here, impressively large expansions of CD8+
T cells are observed that bias the overall CD8 T cell pool durably
toward an effector memory (TEM) phenotype (Snyder, 2011;
O’Hara et al., 2012; Klenerman and Oxenius, 2016).
These chronic viral infections affect immune responsiveness,
e.g., by inducing and sustaining altered baseline levels of
proinﬂammatory or immunomodulatory cytokines, by boosting
innate immune responsiveness, and by changing the composi-
tion of lymphocyte populations as well as the function of APCs
(Virgin et al., 2009). Indeed, substantial and sustained loss of
“bystander” memory T cells was reported in chronic LCMV in-
fection (Kim and Welsh, 2004), as well as impaired effector to
memory transition of primed non–virus-speciﬁc CD8+ T cells
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(Stelekati et al., 2014). Also, in the context of HIV-1 infection,
bystander T cells acquired an activated phenotype in individuals
stopping antiretroviral therapy and hence experiencing viral
rebound (Bastidas et al., 2014). Thus, thorough investigations on
how speciﬁc persistent viral infections change immune re-
sponsiveness are of considerable importance, not only in the
context of how persistent viruses affect immune homeostasis
but also for predicting vaccine responsiveness or immune
competence to control heterologous infections.
Here, we assessed the consequences of active chronic LCMV
infection on existing heterologous immunity (memory by-
stander T cells). Chronic LCMV infection substantially reduced
total numbers of existing heterologous memory CD8+ T cells
through a mechanism that was partially dependent on perforin-
mediated cytotoxicity, leading to disruption of splenic micro-
architecture and hence survival niches. In functional terms,
bystander memory CD8+ T cells exhibited a reduced capacity to
produce inﬂammatory cytokines such as IFNγ and TNF. Phe-
notypically, bystander memory CD8+ T cells acquired a cell
surface marker expression proﬁle reminiscent of effector/ex-
hausted cells, largely induced by IL-6. Transcriptional proﬁling
of bystander memory cells corroborated the acquisition of ex-
hausted signatures and revealed a gene expression proﬁle in-
duced by inﬂammatory cytokines rather than TCR triggering.
Moreover, chronic virus infection negatively impacted the sec-
ondary expansion of memory bystanders upon challenge within
chronically infected hosts. However, upon isolation of bystander
memory T cells from an infected host and transfer into a naive
environment, they resumed their memory potential. This in-
dicates a superior role of the chronically infected host envi-
ronment in restricting the functional capacities of bystander
memory CD8+ T cells rather than durable cell-intrinsic func-
tional alterations of memory bystander CD8+ T cells.
Results
Chronic virus infection signiﬁcantly reduces total numbers of
memory bystander T cells
To investigate the impact of chronic virus infection on memory
bystander CD8+ T cells, we adoptively transferred naive CD45.1+
TCR-transgenic, OVA257–264-speciﬁc (OT-I) CD8+ T cells into
congenic CD45.2 WT C57BL/6 mice and generated OT-I memory
cells by infection with recombinant vaccinia virus expressing
OVA (VV-OVA). At least 30 d after infection, after an OVA-
speciﬁc memory T cell pool had been established, mice were
infected with either an intermediate or high dose of LCMV
docile, leading to protracted infection with different rates of
control (the intermediate dose is cleared by day 30 after infec-
tion, whereas a high-dose infection results in a chronic infection
lasting until approximately day 300 after infection; Fig. 1, A and
B). At 30 d after LCMV infection, the absolute number of
memory OT-I T cells was strongly reduced upon chronic LCMV
infection in spleen, lung, and blood. This effect was most pro-
nounced upon a high-dose LCMV infection (Fig. 1 C).
To investigate whether this numeric reduction was due to an
actively replicating chronic virus infection, we performed the
same experiment using murine CMV (MCMV) instead of LCMV.
MCMV is a β herpes virus that, after control of lytic replication,
persists in a latent form with recurrent episodes of reactivation.
MCMV infection also leads to a signiﬁcant reduction in memory
bystander T cells in different organs (Fig. S1 A). We therefore
tested whether this effect was exclusively true for chronic virus
infection by infecting mice harboring memory bystander T cells
with 200 focus-forming units (ffu) of the LCMV WE strain in
order to cause an acute virus infection (Fig. S1 B). Interestingly,
acute virus infection reduced total numbers of memory by-
stander T cells to a lesser extent than chronic virus infection
(Fig. S1 B). These data highlight a common effect of chronic virus
infections with an active replication or alternate stages of re-
activation and latency on signiﬁcant reduction in total numbers
of memory bystander T cells in secondary lymphatic and pe-
ripheral organs.
Loss of memory bystander T cells is partially due to
perforin-mediated cytotoxicity
To investigate whether this numeric reduction of memory by-
stander T cells by chronic virus infections was due to compro-
mised survival niches in secondary lymphoid organs, for
instance, by perforin-mediated destruction of T cell zone stro-
mal structures by CD8+ T cells, we sortedmemory bystander OT-I
T cells ≥30 d after VV-OVA infection, transferred them in equal
numbers either into WT or perforin-deﬁcient (PKOB−/−) mice
and infected the mice 1 d after transfer with LCMV docile (Fig. 2
A). At day 10 after infection, total numbers of the memory by-
stander T cells in the spleen and in the lung of WT recipients
were reduced 17- and 7-fold, respectively. In contrast, this nu-
meric reduction was signiﬁcantly less pronounced (threefold in
spleen and lung) in PKOB−/− mice upon chronic LCMV infection
(Fig. 2 B). Interestingly, the memory bystander T cells in WT
mice signiﬁcantly down-regulated IL-7Rα expression upon
LCMV infection in the spleen and in the lung, which could ex-
plain diminished survival due to reduced sensing of IL-7. The
decreased expression of IL-7Rα was not observed in the absence
of perforin upon LCMV infection (Fig. 2 B). To compare sec-
ondary lymphoid organ integrity in the presence or absence of
perforin, and in particular the localization of T cells, we analyzed
spleen sections of infected and uninfected WT or PKOB−/− mice
by ﬂuorescence microscopy. In uninfected mice, T cells reside in
podoplanin-positive T cell zones, surrounded by the B cell zone
(Fig. 2 C). Upon LCMV infection, T cells were mostly found
outside podoplanin-positive T cell zones, and this spatial sepa-
ration was far less pronounced in LCMV-infected PKOB−/− mice.
To quantify T cell localization within podoplanin-positive
T cell zones, we selected a region of interest (ROI) based on
podoplanin staining, measured the volume of CD3 and podo-
planin stainings, and calculated the ratio of volume of CD3 to
volume of podoplanin per ROI. This ratio was signiﬁcantly re-
duced in WT mice upon LCMV infection, whereas this was not
the case in the absence of perforin (Fig. 2 D), even though the
volume of podoplanin per ROI was comparable among all groups
(Fig. 2 D, bottom graph). Since the absence of perforin did not
fully restore total numbers of memory bystander T cells, we
further tested a potential involvement of natural killer (NK) cells
and virus-speciﬁc effector CD8+ T cells (Fig. S1 D). The depletion
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of NK cells had no effect on reducedmemory bystander numbers
(Fig. S1 D), whereas the presence of virus-speciﬁc effector CD8+
T cells did slightly reduce total numbers of memory bystander
T cells (Fig. S1 E). These ﬁndings indicate that the loss of
memory bystander T cells upon chronic LCMV infection is to a
signiﬁcant extent caused by perforin-mediated cytotoxicity and
resultant disruption of splenic microarchitecture.
Chronic virus infection skews memory bystander phenotype
and function
To examine the impact of a chronic virus infection on the phe-
notype and function of memory bystander T cells, we trans-
ferred CD45.1+ OT-I CD8+ T cells into congenic CD45.2+ WT
C57BL/6 mice, followed by priming with VV-OVA. At least 30 d
after priming, the mice were infected with intermediate- or
high-dose LCMV docile. The memory bystander OT-I T cells
were phenotypically and functionally analyzed 30 d after LCMV
infection (Fig. 3 A). At this time point (60 d after VV-OVA in-
fection), memory CD8+ T cells typically express high levels of IL-
7Rα and very low levels of KLRG1. However, in LCMV-infected
mice the expression of IL-7Rα was severely reduced on the
memory bystander T cells compared to controls. In addition, the
proportion of KLRG1+ cells was markedly increased, suggesting a
conversion of the memory phenotype to more of an effector
phenotype, or a selective loss of the IL-7Rα+ compartment in the
presence of chronic LCMV infection (Fig. 3 B). Interestingly,
there was a correlation between phenotype and viral dose, with
a higher percentage of KLRG1+ IL-7Rα− bystander memory OT-I
T cells in mice infected with a high dose of LCMV docile in
comparison to intermediate-dose infection. Importantly, these
phenotypic changes were not caused by cross-reactivity be-
tween the OT-I TCR and LCMV antigens (Fig. S2 A). To further
exclude the possibility that this phenomenon is due to “antigen-
speciﬁc” activation of the bystander CD8+ T cells facilitated by
the expression of a second TCR α chain, we analyzed CD8+ OT-I
bystander T cells from Rag1−/− mice (Fig. S2 D). Comparable
phenotypic changes were observed in RAG1+/+ and RAG1−/− OT-I
memory bystander cells, excluding a role of endogenous α
chains that might confer LCMV reactivity to the OT-I T cells.
The phenotypical changes on memory bystander OT-I cells
were exclusively induced by chronic and not by acute virus
infection (Fig. S2 B). Moreover, IL-2, TNFα, and IFNγ cytokine
production after in vitro restimulation with cognate antigen
was signiﬁcantly reduced in memory bystander T cells that
were exposed to a chronic LCMV infection as compared with
uninfected controls (Fig. 3 C). Of note, similar phenotypical,
functional, and numeric alterations were also observed when
fully formed memory bystander OT-I CD8+ T cells were adop-
tively transferred into recipients with already established
chronic LCMV infection at 30 d after transfer (Fig. 3 D and
Fig. S2 C).
Since chronic LCMV infection had a signiﬁcant impact on the
functionality of memory bystander T cells with respect to their
ability to produce effector cytokines after restimulation, we
further characterized these cells for expression of the co-
inhibitory receptor PD-1 and the exhaustion marker CD39
Figure 1. Chronic virus infection signiﬁcantly reduces total numbers of memory bystander T cells. (A) Experimental approach. Adoptive transfer of
CD45.1+ TCR-transgenic OVA257–264-speciﬁc (OT-I) CD8+ T cells into congenic CD45.2 WT C57BL/6 mice, followed by priming with VV-OVA. On day 30 after
priming, mice were infected with the persistent docile strain of LCMVwith an intermediate (104 ffu) or high (106 ffu) dose. The experiment was terminated 30 d
after LCMV infection. (B) Viral titers in liver and kidney at day 30 after infection. (C) Total cell counts of OT-I memory bystander CD8+ T cells in spleen, lung,
and blood of memory only (white, no LCMV infection), memory + LCMV intermediate dose (gray), and memory + LCMV high-dose (black) 30 d after infection.
(B and C)One representative experiment out of two is shownwith four to ﬁve mice per group. Statistical analysis was performed using the unpaired two-tailed
Student’s t test: *, P < 0.05; ***, P < 0.001; ****, P < 0.0001. Error bars show SEM.
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(Gupta et al., 2015). Interestingly, the memory bystander T cells
expressed signiﬁcantly higher levels of PD-1 exclusively upon
chronic LCMV but not upon acute LCMV infection (Fig. S2 E).
Additionally, bystander OT-I T cells coexpressed CD39 (Fig. S2
F), a marker that is typically expressed on exhausted CD8+
T cells and identiﬁes CD8+ T cells with impaired function (Gupta
et al., 2015). Thus, chronic viral infection, in contrast to resolved
viral infection, signiﬁcantly alters the phenotype and function of
CD8+ memory bystander T cells.
KLRG1+ population arises from the IL-7Rαlow compartment
Next, we addressed the question whether the KLRG1+ IL-7Rα−
phenotype was the result of a phenotypical conversion or of a
selective loss of the KLRG1− IL-7Rα+ bystander CD8+ T cells in
the setting of chronic LCMV infection. We therefore sorted
memory OT-I cells with either low or high levels of IL-7Rα
expression and transferred equal numbers into naive C57BL/6
mice, followed 1 d later by chronic LCMV infection. The
phenotype of the memory bystander subsets was analyzed
2 wk after infection (Fig. 4 A). As depicted in Fig. 4 B, the
memory bystander T cells from the IL-7Rαlow subset signiﬁ-
cantly up-regulated KLRG1 upon LCMV infection in the spleen
and the lung, whereas the IL-7Rαhigh subset did not up-
regulate KLRG1, indicating that chronic LCMV infection in-
duces a conversion of the phenotype of the IL-7Rαlow subset to
a KLRG1+ phenotype.
Figure 2. Loss of memory bystander T cells partially due to perforin-mediated cytotoxicity. (A) Experimental approach. Adoptive transfer of CD45.1+
OT-I memory CD8+ T cells (≥30 d after VV-OVA infection) into congenic CD45.2 WT C57BL/6 or PKOB−/− mice. Mice were infected with LCMV docile 1 d after
transfer. The experiment was terminated 10 d after LCMV infection. (B) Top: Total cell counts of OT-I memory bystander CD8+ T cells in spleen and lung of
memory only inWT (black, uninfected), memory + LCMV inWT (white), memory only in PKOB−/− (dark gray, uninfected), and memory + LCMV in PKOB−/− (light
gray). Bottom: Quantiﬁcation of IL-7Rα+ OT-I T cell percentages in spleen and lung of memory only in WT (black, uninfected), memory + LCMV in WT (white),
memory only in PKOB−/− (dark gray, uninfected), and memory + LCMV in PKOB−/− (light gray). One representative experiment out of two with four mice per
group is shown. Statistical analysis was performed using the unpaired two-tailed Student’s t test: ns, P ≥ 0.05; **, P < 0.01; ****, P < 0.0001. (C) Immu-
noﬂuorescence staining of splenic thin sections of WT (top row), WT+LCMV (second row from top), PKOB−/− (third row from top), or PKOB−/− + LCMV (bottom
row) for B cell zone (B220+, red), T cell zone (podoplanin, yellow), and T cells (CD3+, white). Scale bar, 90 µm. ROI, dashed white line. (D) Top: Ratio of volume
of CD3 to volume of podoplanin in the ROI. 20 ROIs were analyzed per group. Bottom: Ratio of volume of podoplanin per ROI. Twenty ROIs were analyzed per
group. Error bars show SEM.
Barnstorf et al. Journal of Experimental Medicine 4
Bystander memory CD8 T cells in chronic infections https://doi.org/10.1084/jem.20181589
Figure 3. Chronic virus infection skews memory bystander phenotype and function. (A) Experimental approach. Adoptive transfer of CD45.1+ OT-I CD8+
T cells into congenic CD45.2WT C57BL/6 mice, followed by priming with VV-OVA. On at least day 30 after priming, the mice were infected with LCMV docile at
an intermediate (104 ffu) or high (106 ffu) dose. The experiment was terminated 30 d after LCMV infection. (B) Memory bystander CD8+ T cells in the spleen,
lung, and blood. Flow cytometry plots pregated on live CD8+ T cells from spleen are depicted. Representative FACS plots are shown for CD45.1+ bystander
Barnstorf et al. Journal of Experimental Medicine 5
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Transcriptional proﬁle of memory bystander CD8 T cells
induced by chronic virus infection
To investigate the molecular cues triggering these phenotypical
changes in memory bystander cells during chronic LCMV in-
fection, we analyzed gene expression proﬁles of OT-I memory
cells that had or had not been exposed to chronic LCMV infec-
tion by RNA sequencing (RNA-seq). The transcriptional proﬁle
of the bystander T cells that were exposed to chronic LCMV
infection (+LCMV) was distinct from the uninfected memory
control (memory; Fig. 5 A). Comparing the expression proﬁles of
genes associated with T cell differentiation revealed an up-
regulation of genes encoding coinhibitory molecules such as
CD39, PD-1, Tim-3, CTLA-4, 2B4, and TIGIT and down-regulation
of IL-7Rα, CD62L, and CD44 (Fig. 5 B), which is in line with the
ﬂow cytometry data showing amore exhausted phenotype of the
memory bystander T cells upon chronic virus infection. The
transcriptional signatures revealed a robust up-regulation of
inﬂammatory cytokines such as IL-6, IL-21, IL-1α, and IL-1β upon
chronic LCMV infection, but also a down-regulation of T cell
effector cytokines and molecules such as perforin, IFNγ, and
granzyme B compared with memory bystanders that had not
been exposed to chronic virus infection. The expression of
transcription factors associated with memory formation or
maintenance shows that T-bet, which is highly expressed in
effector CD8+ T cells and declines in its expression uponmemory
formation (Kaech and Cui, 2012), is down-regulated upon ex-
posure to chronic virus infection. Strikingly, Tcf1, which is
usually expressed in long-lived memory T cells (Sarkar et al.,
2008; Kaech and Cui, 2012), is down-regulated. The down-
regulation of Foxo1 also indicates that the bystander T cells ex-
posed to chronic LCMVhave an alteredmemory gene expression
proﬁle. Thus, the transcriptional proﬁle of memory bystanders
that were exposed to chronic virus infection versus controls
reveals features of exhausted, and to some extent also “effector-
like,” cells. To elucidate which cell type they resemble more, we
compared the transcriptional proﬁle of LCMV-exposed by-
stander cells with differential gene expression proﬁles between
effector LCMV-speciﬁc CD8+ T cells andmemory T cells (Fig. 5 C,
left) and between exhausted LCMV-speciﬁc CD8+ T cells and
memory T cells (Fig. 5 C, right; Wherry et al., 2007). Red points
correspond to those genes reported as up-regulated in the ef-
fector T cell gene set (Fig. 5 C, left) or exhausted T cell gene set
(Fig. 5 C, right), whereas blue points correspond to those genes
reported as down-regulated in the effector T cell gene set (Fig. 5
C, left) or exhausted T cell gene set (Fig. 5 C, right). This analysis
revealed that the memory bystander T cells that were exposed to
T cells (memory only, + LCMV intermediate, and + LCMV high) and their expression of KLRG1 and IL-7Rα. Right: Quantiﬁcation of percentages of KLRG1+ IL-
7Rα− OT-I T cells and KLRG1− IL-7Rα+ OT-I T cells shown for memory only (white, uninfected), + LCMV intermediate dose (gray), and + LCMV high dose (black)
in the spleen and lung. FSC-H, forward scatter height. (C) Representative ﬂow cytometry plots of cytokine production and quantiﬁcation of IFNγ, IL-2, and
TNFα production by memory bystanders from memory only (white, uninfected), + LCMV intermediate dose (gray), and + LCMV high dose (black) in the lung
after 6 h of restimulation with the cognate antigen. (D) Left: Experimental approach. Mice were infected with a high-dose LCMV docile. 30 d after infection,
memory bystander CD8+ T cells were adoptively transferred into chronically infected mice. Bystander T cells were analyzed 30 d after transfer. Right:
Quantiﬁcation of percentages of KLRG1+ IL-7Rα− OT-I T cells and KLRG1− IL-7Rα+ OT-I T cells shown for memory only (white, uninfected) and + LCMV (black) in
the spleen and lung. (B–D)One representative experiment out of two is shown with four mice per group. Statistical analysis was performed using the unpaired
two-tailed Student’s t test: ns, P ≥ 0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Error bars show SEM.
Figure 4. KLRG1+ population arises from the
IL-7Rαlow compartment. (A) Experimental ap-
proach. Adoptive transfer of CD45.1+ OT-I CD8+
T cells into congenic CD45.2 WT C57BL/6 mice,
followed by priming with VV-OVA. On day 30
after priming, OT-I memory cells were sorted for
KLRG1− IL-7Rαlow and KLRG1− IL-7Rαhigh and
adoptively transferred into age- and sex-
matched naive mice. 1 d after transfer, mice
were chronically infected with LCMV docile. The
experiment was terminated 15 d after LCMV in-
fection. (B) Memory bystander CD8+ T cells in
spleen and lung. Left: Flow cytometry plots
pregated on live CD8+ T cells are shown. Rep-
resentative FACS plots for CD45.1+ memory only
and memory + LCMV and their expression of
KLRG1 and IL-7Rα. Right: Quantiﬁcation of per-
centages of KLRG1+ IL-7Rα− OT-I T cells are
shown for IL-7Rα+ (white) and IL-7Rα− (black) in
the spleen and lung. FSC-H, forward scatter
height. One representative experiment out of
two is shownwith ﬁvemice per group. Statistical
analysis was performed using the unpaired two-
tailed Student’s t test: *, P < 0.05; ****, P <
0.0001. Error bars show SEM.
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a chronic virus infection more closely resemble exhausted
LCMV-speciﬁc CD8+ T cells, since 181 of 184 down-regulated
genes and 100 of 182 up-regulated genes in exhausted CD8+
T cells were matching with our dataset. The comparison to the
effector versus memory dataset revealed 168 matches of
187 down-regulated genes but only 43 matches of 184 up-
regulated genes (Fig. 5 C).
Functionally, we had no indication that the OT-I bystander
memory cells were activated by chronic LCMV infection in a
TCR-dependentmanner. However, to conﬁrm these ﬁndings, we
compared gene expression proﬁles associated with the TCR
signaling pathway between memory OT-I cells that were or
were not exposed to LCMV and found a robust down-regulation
of TCR signaling pathway–associated genes upon LCMV expo-
sure (Fig. S3 A). Since LCMV infection is characterized by a
strong and sustained induction of type I IFNs, we focused on the
gene signatures of IFN-stimulated genes and observed a mix of
up-regulated and down-regulated genes (Fig. S3 B).
In summary, the transcriptional analysis of bystander
memory T cells revealed a profound change toward a more ex-
hausted than effector-like gene expression signature during
chronic virus infection. Based on the absence of signatures
Figure 5. Transcriptional proﬁle of memory bystander CD8+ T cells induced by chronic virus infection. (A) Heat map of differentially expressed genes
comparing memory only (memory, uninfected) and memory + LCMV (+LCMV) infection. (B) Heat maps for selected genes of interest separated into categories
of T cell differentiation, cytokines, and transcription factors comparing memory only (memory, uninfected) and memory + LCMV (+LCMV) infection. (C) Log2
fold change (Log2FC) and accompanying P values are shown for genes reported in four gene sets (Wherry et al., 2007). Red points correspond to those genes
reported as up-regulated in the effector T cell gene set (left) or exhausted T cell gene set (right), whereas blue points correspond to those genes reported as
down-regulated in the effector T cell gene set (left) or exhausted T cell gene set (right).
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associated with TCR signaling pathways, we assumed that these
changes are mainly caused by the inﬂammatory cytokine milieu
rather than by antigenic triggering.
IL-6 drives phenotypic alterations of memory bystander T cells
The robust enrichment of cytokine-related genes in memory
bystander CD8+ T cells in the presence of a chronic virus in-
fection led us to examine whether a speciﬁc cytokine might be
responsible for the observed phenotypical changes. We there-
fore determined the phosphorylation status of different STAT
proteins directly ex vivo and observed a strong pSTAT1 signa-
ture in the memory bystander T cells upon LCMV infection
under viremic conditions (Fig. S4 A). Additionally, we per-
formed a cytometric bead array (CBA) for IL-6, IFNγ, and TNF,
as well as a bioassay for type I IFNs, comparing naive mice with
LCMV-infected hosts. Interestingly, TNF and IL-6 levels were
signiﬁcantly elevated in the serum (Fig. 6 A) and the spleen and
the lung (Fig. S4 C) even 30 d after LCMV infection. Since type I
IFNs play a major role during LCMV infection and signal via
STAT1, we blocked the type I IFN receptor (IFNAR) with a
blocking antibody >2 wk during chronic LCMV infection and
compared numeric and phenotypic changes of bystander OT-I
memory CD8+ T cells in the presence or absence of IFNAR
blocking antibodies. Surprisingly, blocking of IFNAR did not
affect the typical phenotypic changes imposed by chronic by-
stander LCMV infection, nor did it rescue the attrition of
memory bystander cells (Fig. S4 D), despite abrogation of the
ex vivo STAT1 phosphorylation (Fig. S4 B). Neutralization of
other cytokines associated with STAT1 signaling like IL-7, IL-2,
and IFNγ did also not have an impact on the number or phe-
notype of memory bystander T cells upon LCMV infection (Fig.
S4 E). Since the RNA-seq data and serum cytokine levels re-
vealed IL-6 as a possible candidate and since IL-6 is known to
signal via STAT1 and STAT3, we next blocked the IL-6R from the
onset of LCMV infection (Fig. 6 B, top). Indeed, blocking IL-6R
completely reversed the phenotypic alterations imposed by
chronic LCMV infection, as KLRG1 and IL-7Rα expression levels
were comparable in LCMV-exposed and -unexposed memo-
ry bystander CD8+ T cells (Fig. 6 B). Of note, during chronic
LCMV infection, a majority of bystander KLRG1+ OT-I T but not
KLRG1− OT-I cells expressed high levels of IL-6Rα and ∼10% of
IL-7Rα− memory OT-I cells already expressed IL-6Rα before
LCMV infection (Fig. S5), and IL-7Rα− memory OT-I cells were
shown to up-regulate KLRG1 during chronic LCMV infection
(Fig. 4).
IL-6 blockade, however, did not affect the attrition of mem-
ory bystander cells (Fig. S4 F). To test whether IL-6 alone can
induce the observed phenotypical changes, we injected 1 µg
recombinant IL-6 (rIL-6) per day for 7 d into mice harboring
memory OT-I CD8+ T cells (Fig. 6 C). Indeed, memory bystander
T cells signiﬁcantly up-regulated KLRG1 in the spleen and in the
lung upon IL-6 treatment without infection, suggesting that IL-6
alone can alter the phenotype of memory bystander T cells.
Next, we investigated whether IL-6 acts directly on the memory
bystander T cells. We sorted memory OT-I T cells and cultured
them in the presence of rIL-6 (Fig. 6 D). Memory OT-I T cells up-
regulated KLRG1 in the presence of rIL-6.
Since IL-6 is also signaling via STAT1 and memory bystander
T cells showed a strong ex vivo pSTAT1 signature upon chronic
virus infection, we tested phenotypic alterations in CD8+ OT-I
memory bystander T cells lacking STAT1. Therefore, we adop-
tively transferred equal numbers of memory CD8+ OT-I T cells
with WT or Stat1−/− background into naive C57BL/6 recipients
and infected these mice 1 d after transfer with a chronic dose of
LCMV. Indeed, chronic virus infection did not induce pheno-
typic alterations toward an “effector-like” phenotype in Stat1−/−
OT-I bystander T cells (Fig. 6 E). To corroborate that IL-6 signals
via STAT1 in memory CD8+ T cells, we stained for pSTAT1 and
pSTAT3 after 6 h of in vitro stimulation with rIL-6 and found
that IL-6 signals via pSTAT1 in memory bystander T cells
(Fig. 6 F). Together, these data suggest that high levels of IL-6
induced by chronic virus infection drive phenotypic alterations
of memory bystander T cells in a direct, STAT1-dependent
manner.
Chronic viral infection negatively impacts secondary
expansion and protection of memory bystanders in a
cell-extrinsic manner
Next, we analyzed whether a hallmark of memory CD8+ T cells,
namely their rapid and pronounced recall response, was affected
by chronic LCMV infection. Therefore, we transferred CD45.1+
OT-I CD8+ T cells into congenic CD45.2 WT C57BL/6 mice and
induced memory OT-I CD8+ T cells by infection with recombi-
nant vesicular stomatitis virus expressing OVA (VSV-OVA),
followed by chronic LCMV infection 30 d after priming. 30 d
after chronic LCMV infection, we challenged the memory by-
stander T cells with VV-OVA and analyzed the secondary ex-
pansion 8 d after VV-OVA challenge (Fig. 7 A). Strikingly, the
memory bystander T cells that were exposed to chronic LCMV
infection expanded to a much smaller extent than controls upon
challenge with their cognate antigen (e.g., 18-fold less in the
lung; Fig. 7 A). Since viral replication of VV-OVA was slightly
reduced if the host was chronically LCMV infected (Fig. 7 C), we
wanted to conﬁrm these results by using a boosting strategy that
would not rely on viral replication. To this end, we used SIIN-
FEKL peptide combinedwith CpG as an adjuvant to challenge the
bystander T cells and analyzed the expansion 8 d after challenge
(Fig. 7 B). We could conﬁrm that memory bystanders expanded
to a much lower extent if exposed to a chronic virus infection.
Upon peptide challenge, bystander CD8+ OT-I T cells even ex-
panded 475-fold less than controls (Fig. 7 B). Next, we tested the
protective capacity of memory bystander CD8+ T cells with and
without exposure to chronic LCMV infection. To this end, mice
were challenged with VV-OVA 30 d after LCMV infection and
viral titers were quantiﬁed in ovaries 8 d after challenge (Fig. 7
C). We found that bystander T cells that had been exposed to a
chronic virus infection conferred up to 3-log less protection
compared with bystander T cells that had not been exposed to
the chronic environment (Fig. 7 C).
To assess whether the reduced expansion potential of
memory OT-I T cells in chronic LCMV-infected hosts was a re-
sult of cell-intrinsic or cell-extrinsic factors, we adoptively
transferred memory bystander OT-I T cells that either had or
had not been exposed to LCMV into naive hosts and challenged
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Figure 6. IL-6 drives phenotypic alterations of memory bystander T cells. (A) Cytokine levels in the serum over 30 d of infection (LCMV, open squares)
and naive controls (naive, gray circles, gray area) were measured by CBA (IL-6, IFNγ, and TNF) or IFN bioassay (type I IFNs). (B) Top: Experimental approach.
Adoptive transfer of CD45.1+ OT-I CD8+ T cells into congenic CD45.2 WT C57BL/6 mice, followed by priming with VV-OVA. On day 30 after priming, mice were
persistently infected with LCMV docile. From the onset of the infection, αIL-6R blocking antibody was injected i.p. every second day. The experiment was
terminated 15 d after LCMV infection. Middle: Representative ﬂow cytometry plots of the expression of KLRG1 and IL-7Rα of memory only, + LCMV, and +LCMV
+ αIL-6R. Bottom: Quantiﬁcation of percentages of KLRG1+ IL-7Rα− OT-I T cells shown for memory only (white, uninfected) + LCMV (black), and +LCMV + αIL-
6R (gray) in the spleen, lung, and blood. (C) Top: Experimental approach. Adoptive transfer of CD45.1+ OT-I CD8+ T cells into congenic CD45.2 WT C57BL/6
mice, followed by priming with VV-OVA. On day 30 after priming, mice were injected with 1 µg of rIL-6 every day for 1 wk. Bottom: Quantiﬁcation of per-
centages of KLRG1+ IL-7Rα− OT-I T cells shown for memory only (white, uninfected) and +rIL-6 (black) in the spleen and lung. (D) Top: Experimental approach.
FACS-sorted memory OT-I CD8+ T cells were cultured in vitro with or without rIL-6 for 3 d. Bottom: Quantiﬁcation of percentages of KLRG1+ OT-I T cells shown
for no cytokine (w/o, white), 0.25 µg/ml (light gray), and 0.5 µg/ml (dark gray). (E) Top left: Experimental approach. Adoptive transfer of 5 × 105 CD45.1+ WT
memory OT-I or CD45.1+ Stat1−/− memory OT-I CD8+ T cells into congenic CD45.2+ WT C57BL/6 mice. 1 d after transfer, mice were persistently infected with
Barnstorf et al. Journal of Experimental Medicine 9
Bystander memory CD8 T cells in chronic infections https://doi.org/10.1084/jem.20181589
these mice with VV-OVA. Surprisingly, the cells expanded to the
same extent in spleen and lung, independent of their history
(Fig. 7 D), indicating that the impaired secondary expansion
within chronically infected hosts was due to cell-extrinsic fac-
tors. Since these extrinsic factors are likely associated with
ongoing viral replication, we asked the questionwhether normal
secondary expansion potential would be reached in chronically
infected hosts after eventual control of LCMV infection. There-
fore, we adoptively transferred CD45.1+ OT-I CD8+ T cells into
congenic CD45.2+ WT C57BL/6 mice, primed with VV-OVA and
chronically infected with LCMV 30 d later. We performed lon-
gitudinal focus-forming assays from the blood of the chronically
infected mice to determine when the mice controlled the in-
fection. At 300 d after LCMV infection, no focus-forming units
were detectable, and we analyzed the spleen and the lung for the
phenotype of thememory bystander T cells. Interestingly, at this
time point, IL-7Rα expression was restored to the same level as
observed in LCMV uninfected mice. Additionally, KLRG1 ex-
pression was signiﬁcantly decreased in these long-term by-
standers but still slightly elevated compared with uninfected
controls (Fig. 7 E).
These data show that viral clearance leads to partial reversion
of the phenotypic alterations induced by chronic viral infection.
To assess whether this also holds for the functional alterations,
we performed in the same long-term experiment a challenge
with SIINFEKL peptide and CpG-containing oligonucleotides as
adjuvant once the chronic infection had resolved. Surprisingly,
secondary expansion remained highly compromised in the
spleen and in the lung, even though long-term memory by-
stander cells expanded slightly better in the lung compared with
earlier time points of chronic infection (day 30; Fig. 7 F). These
results suggest that, in addition to causing attrition of memory
CD8 T cell numbers and skewing of the memory phenotype,
chronic virus infection impacts markedly on the secondary ex-
pansion potential of memory bystander CD8+ T cells in a cell-
extrinsic manner and thus severely hampers their protective
capacity.
Discussion
While there is substantial knowledge about the impact of
chronic viral infections on the regulation of virus-speciﬁc T cell
immunity, much less is known about their inﬂuence on unre-
lated, heterologous T cell phenotypes and functions. We re-
vealed a profound impact of chronic virus infections on existing
heterologous immunity, focusing on memory bystander CD8+
T cells with speciﬁcity for OVA. Fully formed memory T cells
were strongly reduced in total numbers in different organs,
which could be partly explained by the inﬂuence of perforin-
mediated cytotoxicity of the virus-speciﬁc CD8+ T cells, leading
tomarked destruction of secondary lymphoid organ architecture
and, in particular, possibly reduced IL-7–sensing opportunities.
Previous studies have shown attrition of memory CD8+ T cells by
heterologous virus infections, demonstrating that type I IFNs
induced by the viral infection were driving apoptosis of by-
stander memory T cells during the early phase of infection
(McNally et al., 2001; Jiang et al., 2005; Bahl et al., 2006). Still, it
remained controversial whether this selective loss of memory
bystanders was indeed due to active attrition as result of apo-
ptosis or whether it was rather due to competition for niches
between virus-speciﬁc and bystander cells, described as passive
attrition (Welsh and Selin, 2009). There is clear evidence of
virus-induced lymphopenia causing apoptosis and thereby re-
ducing memory bystanders at the early stages of several viral
infections (McNally et al., 2001; Peacock et al., 2003) and of type
I IFNs causing apoptosis and the following forfeiture of CD44high
CD8+ T cells (McNally et al., 2001). The survival of bystander
memory T cells is based on the frequency of competing, newly
generated memory cells, pursuant to the passive competition
model. However, we show here that the loss of bystander T cells
occurs already before virus-speciﬁc CD8+ T cells expand (Fig. S1
C) and is most pronounced upon chronic virus infection.
Therefore, these observations favor the active deletion model,
but more comprehensive research is needed to resolve this
question (Kim and Welsh, 2004). Interestingly, not only type I
IFNs but also type II IFNs (IFNγ) induce a durable loss of by-
stander memory CD8+ T cells upon challenge with intracellular
bacteria, which has also been linked to active attrition rather
than competition (Dudani et al., 2008). These studies indicate
that memory attrition can be induced by type I and type II IFNs.
We could also show that type I and type II IFNs were highly
elevated early during chronic virus infection; nevertheless, their
neutralization with the onset of chronic infection did not restore
total numbers (Fig. S4).
Besides the loss of total numbers of memory bystander CD8+
T cells, we also revealed a pervasive effect of chronic virus in-
fections on the phenotype and function of these T cells. These
changes manifested toward a more exhausted-like phenotype
and a reduced ability to produce effector cytokines. On a tran-
scriptional level, LCMV-exposed bystander memory cells ex-
hibited a signature that was closer to exhausted than effector
T cells and also expressed higher levels of these markers on the
protein level. IL-6 proved to be a major driver of these pheno-
typical changes in a T cell–intrinsic manner. Canonical memory
CD8+ T cell properties, such as rapid secondary expansion, were
severely reduced in the context of chronic bystander virus
LCMV docile. The experiment was terminated 15 d after LCMV infection. Top right: Representative ﬂow cytometry plots of the expression of KLRG1 and IL-7Rα
for WT OT-I ± LCMV and Stat1−/− OT-I ± LCMV memory bystander T cells. Bottom: Quantiﬁcation of percentages of KLRG1+ IL-7Rα− OT-I T cells and KLRG1− IL-
7Rα+ OT-I T cells shown for WT (white, uninfected), WT + LCMV (black), Stat1−/− (light gray), and Stat1−/− + LCMV (dark gray) in the spleen and lung.
(F) Experimental approach. FACS-sortedWT or Stat1−/−memory OT-I CD8 T cells were cultured in vitro with or without rIL-6 for 6 h. Bottom: Quantiﬁcation of
mean ﬂuorescence intensity (MFI) of pSTAT1+ and pSTAT3+WT (white) or Stat1−/− (black) OT-I T cells shown for no cytokine (w/o), 500 ng/ml and 1000 ng/ml.
One representative experiment out of two is shown with four to ﬁve mice per group (A–C and E) or triplicates for the in vitro experiments (D and F). Statistical
analysis was performed using the unpaired two-tailed Student’s t test: ns, P ≥ 0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Error bars show
SEM.
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Figure 7. Chronic viral infection negatively impacts secondary expansion and protection of memory bystanders in a cell-extrinsic manner. (A) Top:
Experimental approach. Adoptive transfer of 3 × 105 CD45.1+ OT-I CD8+ T cells into congenic CD45.2WT C57BL/6 mice, followed by priming with VSV-OVA. On
day 30 after priming, mice were persistently infected with LCMV docile. 30 d after LCMV infection mice were infected with VV-OVA. Memory bystanders were
analyzed for expansion 8 d after VV-OVA challenge. Bottom: Quantiﬁcation of fold increase of OT-I T cells shown for memory only (white, uninfected) and +
LCMV (black) in the spleen and in the lung. (B) Top: Experimental approach. Adoptive transfer of CD45.1+ OT-I CD8+ T cells into congenic CD45.2 WT C57BL/6
mice, followed by priming with VV-OVA. On day 30 after priming, mice were persistently infected with LCMV docile. 30 d after LCMV infection a vaccination
boost of 50 µg SIINFEKL peptide and 10 µg CpG was injected intravenously. Memory bystanders were analyzed for expansion 8 d after challenge. Bottom:
Quantiﬁcation of fold increase of OT-I T cells shown for memory only (white, uninfected) and + LCMV (black) in the spleen and in the lung. (C) Top:
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infection. This impairment depended on cell-extrinsic cues in
the chronically infected host and was reverted in a naive envi-
ronment. Collectively, these observations suggest that chronic
virus infections alter multiple features of memory bystander
T cells. Changes are mainly caused by the destruction of sec-
ondary lymphoid organ architecture by virus-speciﬁc CD8+
T cells (with respect to maintenance of memory T cell numbers)
and by the sustained provision of a proinﬂammatory cytokine
milieu (with respect to their phenotypical alterations). Our ex-
periments furthermore ruled out a possible cross-reactivity
between the OT-I TCR and LCMV antigens; treatment of OT-I
T cells with LCMV antigens resulted neither in their activation
nor in the up-regulation of gene expression proﬁles normally
associated with TCR signaling.
Our results complement a previous report showing that
chronic virus infection alters the transition from effector to
memory bystander CD8+ T cells (Stelekati et al., 2014) and, in
addition, give mechanistic details into the molecular pathways
regulating such bystander memory T cell attrition and attenu-
ation. In agreement with our study, Stelekati et al. (2014) found
reduced numbers of bystander CD8+ T cells. They observed that
attrition of CD8+ T cells upon poly(I:C)-induced inﬂammation
was largely due to direct type I IFN signaling on bystander CD8+
T cells. However, in the context of chronic LCMV infection, di-
rect type I IFN signaling on bystander CD8+ T cells only played a
minor role in their numeric reduction and impaired effector to
memory transition. Our study conﬁrms that sustained type I IFN
signaling occurs during chronic LCMV infection, manifested by
IFN-stimulated gene signatures and a directly ex vivo traceable
phosphorylated STAT1 in bystander memory CD8+ T cells.
However, in agreement with the results reported by Stelekati
et al. (2014), we observed that sustained type I IFN signaling did
not induce key phenotypical alterations of bystander memory
CD8+ T cells during chronic LCMV infection, shown by the
failure of IFNAR blockade to revert the infection-induced
changes. Instead, IL-6 signaling via STAT1 proved to be a ma-
jor driver of key phenotypical changes in bystander memory
CD8+ T cells.
IL-6R signaling is known to induce phosphorylation of both
STAT1 and STAT3 in T cells; however, the activation state of
T cells seems to determine whether STAT1 phosphorylation can
occur (Teague et al., 2000). Besides signaling via STATs, IL-6
also engages the Ras–ERK and PI3K–mTOR pathways (Schaper
and Rose-John, 2015). We have observed that LCMV-exposed
memory bystander CD8 T cells signal via STAT1 when treated
with IL-6, but we have not formally analyzed whether IL-6 also
engages the Ras–ERK and PI3K–mTOR pathways in these cells.
Based on our observation that (1) the robust ex vivo pSTAT1
signal in bystander memory cells is abrogated upon IFNAR
blockade, (2) IFNAR blockade does not rescue the phenotypical
alterations in memory bystander cells, and (3) STAT1 de-
ﬁciency in bystander memory T cells prevents the pheno-
typic changes, we hypothesize that additional pathways
involving other signaling intermediates than STAT1 are coop-
erating with STAT1 to mediate the phenotypical changes ob-
served in bystander memory CD8 T cells in the setting of
chronic LCMV infection, likely involving the Ras–ERK and
PI3K–mTOR pathways.
In the context of chronic LCMV infection, IL-6 is produced in
an early (days 1–3 after infection) and late phase (day 25 after
infection), mostly by irradiation-resistant cells (Harker et al.,
2011). Eventual control of an established chronic LCMV infec-
tion is critically dependent on IL-6, which induces the up-
regulation of the transcriptional regulator Bcl-6 in virus-
speciﬁc CD4+ T cells. This supports Tfh differentiation in the
late chronic virus infection and leads to an improved antibody
and an escalated germinal center response. Accordingly, IL-6 has
been suggested to indirectly reduce CD8+ T cell exhaustion in
late chronic LCMV infection via regulation of CD4+ T cell dif-
ferentiation toward Tfh cells and ensuing generation of virus-
neutralizing antibodies (Harker et al., 2011; Wherry and
Kurachi, 2015; Greczmiel et al., 2017). Our results indicate that
the sustained IL-6 production during chronic LCMV infection
also affects T cell phenotypes beyond antigen-speciﬁc T cells. We
show that prolonged IL-6 exposure instructs a transition toward
a more exhausted phenotype in established bystander memory
CD8+ T cells.
Our study highlights the substantial impact of chronic virus
infections on already existing heterologous immunity, which
could serve as a basis to optimize therapeutic strategies and
Experimental approach. Adoptive transfer of 5 × 105 CD45.1+ OT-I memory CD8+ T cells into congenic CD45.2 WT C57BL/6 mice. 1 d after transfer, mice were
persistently infected with LCMV docile; controls remained uninfected. 30 d after LCMV infection, mice were injected intravenously with VV-OVA. Further
controls were WT C57BL/6 mice that were persistently infected with LCMV docile or were left uninfected as controls. VV-OVA titers were analyzed 8 d after
VV-OVA infection in the ovaries. Bottom: Quantiﬁcation of PFUs VV-OVA/ovaries shown for VV-OVA only (circles, white), LCMV + VV-OVA (circles, black),
bystander + VV-OVA (triangle, white), and bystander + LCMV + VV-OVA (triangle, black). (D) Top: Experimental approach. Adoptive transfer of 103 CD45.1+ OT-I
memory CD8+ T cells, which had or had not been exposed to chronic LCMV infection for 30 d, into congenic CD45.2 WT C57BL/6 mice. 1 d after transfer, mice
were infected with VV-OVA. Memory bystanders were analyzed for expansion 8 d after challenge. Bottom: Quantiﬁcation of total numbers of OT-I T cells shown
for memory only (white, uninfected) and + LCMV (black) in the spleen and in the lung. (E) Left: Experimental approach. Adoptive transfer of CD45.1+ OT-I CD8+
T cells into congenic CD45.2 WT C57BL/6 mice, followed by priming with VV-OVA. On day 30 after priming, mice were persistently infected with LCMV docile.
The experiment was terminated after viral clearance at day 300. Right: Quantiﬁcation of percentages of KLRG1+ IL-7Rα− and KLRG1− IL-7Rα+ OT-I T cells shown
for memory only (black, uninfected), + LCMV (day 30, white), and +LCMV long term (day 300, white with black dots) in the spleen and in the lung. (F) Left:
Experimental approach. Adoptive transfer of CD45.1+ OT-I CD8+ T cells into congenic CD45.2 WT C57BL/6 mice, followed by priming with VV-OVA. On day 30
after priming, mice were persistently infected with LCMV docile. After viral clearance at day 300, a vaccination boost of 50 µg SIINFEKL peptide and 10 µg CpG
was injected intravenously. As a control, day 30 LCMV mice were included. Memory bystanders were analyzed for expansion 8 d after challenge. Right:
Quantiﬁcation of fold increase of total OT-I T cells shown for memory only (black, uninfected), + LCMV (day 30, white), and + LCMV long-term (day 300, white
with black dots) in the spleen and in the lung. (A–F) One representative experiment out of two is shown with three to ﬁve mice per group. Statistical analysis
was performed using the unpaired two-tailed Student’s t test: ns, P ≥ 0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Error bars show SEM.
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increases the knowledge of memory development and
maintenance.
Materials and methods
Mice
WTC57BL/6Jmice were purchased from Janvier Elevage. C57BL/
6J (originally from Janvier Elevage), Maxi transgenic (CD45.1)
mice expressing a TCR speciﬁc for MCMV peptide M38316–323
(Torti et al., 2011), P14 transgenic (CD45.1) mice expressing a
TCR speciﬁc for LCMV peptide gp3333–41 (Pircher et al., 1990;
Torti et al., 2011), PKOB−/− (Ka¨gi et al., 1994), CD45.1 OT-I mice
expressing a TCR speciﬁc for OVA257–264 SIINFEKL peptide
(Hogquist et al., 1994), CD45.1 OT-I Rag1−/−, and CD45.1 OT-I
Stat1−/− (the Stat1−/− mice were purchased from Charles River
Laboratories and crossed to the CD45.1 OT-I line) were housed
and bred under speciﬁc pathogen–free conditions at the ETH
Phenomics Center Ho¨nggerberg. All KO and transgenic mice
strains were crossed on a C57BL/6 background for >10 gen-
erations. All mice were used between 6–12 wk of age and sex-
matched within all experiments. All animal experiments were
performed according to the institutional policies and Swiss
federal regulations, and those were approved by the Cantonal
Veterinary Ofﬁce of Zürich (Animal experimentation permis-
sions 228/2013, 166/2016).
Viruses, infections, and depletions
Recombinant MCMV lacking m157 (MCMVΔm157) was previ-
ously described and is referred to as MCMV in this study
(Walton et al., 2008). MCMV strains were propagated on MEFs
(Brune et al., 2001) or M2-10B4 cells (Zurbach et al., 2014), as
previously described. Virus titers in organs were determined by
standard plaque-forming assays on M2-10B4 cells, as previously
described (Zurbach et al., 2014). Mice were intravenously in-
fected with 106 PFU MCMV. LCMV isolates WE and docile were
provided by Dr. R.M. Zinkernagel (University Hospital Zürich,
Zürich, Switzerland) and were propagated at a low multiplicity
of infection (MOI) on L929 ﬁbroblast cells (WE) or Madin-Darby
Canine Kidney endothelial cells (docile). Acute LCMV infection
was induced by i.v. infection with 200 ffu LCMV-WE; chronic
infection was induced by i.v. infection with 2 × 106 ffu LCMV
docile. Recombinant VSV-OVA-GFP was kindly provided by
Dorothee von Laer (Medical University Innsbruck, Innsbruck,
Austria). VSV-OVA-GFP was plaque-puriﬁed as described else-
where (Ebert et al., 2004). To generate virus stocks of VSV-OVA-
GFP on BHK-21 cells, the cells were infected with MOI 0.01, and
after 36 h virus was harvested. Virus supernatant was ﬁltered
(0.45 µm) to remove cell debris and subsequently concentrated
via low-speed centrifugation using a 20% sucrose cushion. Virus
titer was determined on conﬂuent BHK-21 monolayers using
plaque or 50% tissue culture infective dose (TCID50) assay. Mice
were infected intravenously with 2 × 106 PFU. Recombinant VV-
OVA was grown on BSC40 cells at low multiplicity of infection.
Mice were infected i.p. with 106 PFU.
For blockade of IL-6R, 660 µg αIL-6R (clone: 15A7; BioXCell)
was injected i.p. 1 d prior and then every second day after in-
fection for 2 wk. For blockade of IFNAR, 500 µg αIFNAR (clone:
MAR1-5A3; BioXCell) was injected i.p. at day −1, 0, and 1 and
then 250 µg αIFNAR every second day after infection for 2 wk.
For cytokine neutralization, 500 µg anti-IL-7 (M25), 200 µg
anti-IL-2 (JESG-1A12), and 500 µg IFNγ (XMG1.1) were injected
i.p. every third day with the onset of infection for 1 wk. To test
the effect of rIL-6 on memory bystander T cells, 1 µg rIL-6 (re-
combinant human IL-6 [carrier-free]; BioLegend) was injected
i.p. every day for 1 wk.
Virus loads
Virus loads of LCMV were determined in the kidney, liver, or
blood, as described (Battegay et al., 1991). Virus loads of VV were
determined on BSC40 cells after 24 h of incubation (Unger and
Traktman, 2004).
Flow cytometry and lymphocyte stimulation
Cell surface stainings were performed on blood samples, which
were obtained via the leg vein and lymphocytes isolated from
spleens and lungs. Single-cell suspensions were obtained by
mashing spleens through a metal mesh using a syringe plunger.
Blood samples were taken in FACS buffer containing EDTA. For
the preparation of cells from the lung, mice were anaesthetized
with 260 µl ketamine/xylacine/acepromacine mixture (2 mg
ketamine, 0.4 mg xylacine, 60 µg acepromacine in PBS) by i.p.
injection, and the lungs were perfused via the right heart ven-
tricle with ∼5 ml PBS to remove circulating blood. Cells present
in the lung lumen were removed by repeated ﬂushing of the
lumen with 1 ml PBS. The lungs were cut into small pieces and
digested 2 × 20 min at 37°C with complete RPMI containing 2.4
mg/ml collagenase type I (GIBCO BRL Invitrogen) and 0.2 mg/
ml DNase I (Roche Diagnostics), and mononuclear cells were
puriﬁed by gradient centrifugation over 30% Percoll. Complete
RPMI consisted of RPMI (Invitrogen) with 10% FCS (Omnilab),
2 mM L-glutamine (Gibco), and 1% penicillin/streptomycin
(Gibco).
Surface staining of the obtained cells was performed for
20 min at 4°C in PBS. All samples were treated in the following
with 1 ml ACK lysis buffer for RBC lysis for 5 min at room
temperature (RT). Cells were then ﬁxed in PBS containing 1%
paraformaldehyde (PFA). Cytokine expression was analyzed by
intracellular staining in stimulated lymphocytes. CD8 T cells
were stimulatedwith 1 µg/ml of SIINFEKL peptide for 6 h at 37°C
in the presence of monensin A. Surface staining was performed
for 20 min at 4°C followed by permeabilization of the cells with
500 µl of 2 × FACS BD Lysis Solution with 0.08% Tween20 for
10 min at RT. After a washing step, the intracellular staining for
IFNγ, TNF, and IL-2 was performed for 30min at RT in the dark.
Samples were stored in PBS containing 1% PFA. pSTAT1 staining
was performed on lymphocytes directly ex vivo without further
stimulation. Surface staining was performed for 20 min at 4°C
followed by ﬁxation with 4% PFA for 12 min at 37°C. Cells were
permeabilized with 90% methanol for 30 min on ice, and Fc
block was performed in the following with perm buffer + 2% FBS
and Fc block (1:100) for 10 min at RT. Intracellular staining of
pSTAT1 was performed for 45 min in 1× permeabilization/wash
buffer from eBioscience FoxP3 staining kit. Cell proliferation dye
(eBioscience Cell Proliferation Dye eFluor 450) staining was
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performed according to the manufacturer’s protocol.
Fluorophore-conjugated antibodies were purchased from Bio-
Legend (Lucerna Chem AG), eBioscience (Thermo Fisher Scien-
tiﬁc), or BD Biosciences. The following antibodies (clones) were
used for ﬂow cytometry: anti-CD8α (53–6.7), anti-CD45.1 (A20),
anti-KLRG1 (2F1), anti-CD127 (A7R34), anti-pSTAT1 pY701 (4a),
anti-PD-1 (J43), anti-CD39 (Duha59), anti-IFNγ (XMG1.2), anti-
TNF (MP6-XT22), and anti-IL-2 (JES6-5H4). Live/Dead Fixable
near-IR (Life Technologies) dead cell stain was used to exclude
dead cells. Multiparametric ﬂow cytometric analysis was per-
formed using an LSRII ﬂow cytometer (BD Biosciences) and
FACSDiva software. Data were analyzed using FlowJo software
(Tree Star).
Adoptive transfer experiments
CD8 T cells from naive OT-I micewere puriﬁed from splenocytes
using anti-CD8α magnetic activated cell sorting beads (Miltenyi
Biotech) according to the manufacturer’s instructions. 3 × 105
OT-I CD8 T cells were adoptively transferred into recipient mice
1 d before infection. Memory subsets were generated in C57BL/
6J mice and isolated ≥30 d after infection. OT-I memory cells
from the spleen were sorted from donor mice using a BD FAC-
SAria Sorter. Sorted memory OT-I T cells were transferred into
new hosts, used for in vitro assays, or used to extract RNA.
Calculation of fold increase of memory bystander T cells
upon challenge
CD45.1 TCR-transgenic, OVA257–264-speciﬁc (OT-I) CD8+ T cells
were adoptively transferred into congenic CD45.2 WT C57BL/6
mice. Mice were primed with VV-OVA. At least 30 d after
transfer, once an OVA-speciﬁc memory T cell pool had been
established, mice were persistently infected with LCMV docile.
30 d after LCMV infection mice were either sacriﬁced or in-
fected with VV-OVA or injected with SIINFEKL + CpG in order to
boost memory bystander T cells. Total numbers of before and
after boost were calculated for different organs. The fold in-
crease was calculated by dividing the total cell count after boost
by the mean of total count of bystanders before boost:
# bystanders after boost
# bystanders before boost
 fold increase of CD8+ OT − I T cells.
In vitro culture of memory bystander T cells in the presence
of rIL-6
CD45.1 TCR-transgenic, OVA257–264-speciﬁc (OT-I) CD8+ T cells
were adoptively transferred into congenic CD45.2 WT C57BL/6
mice. Mice were primed with VV-OVA. At least 30 d after
transfer, once an OVA-speciﬁc memory T cell pool had been
established, mice were sacriﬁced and lymphocytes were isolated
from the spleen as described before. Cell surface staining was
performed with the following antibodies: anti-CD8α (53–6.7),
anti-CD45.1 (A20). Cells were sorted for CD8+ CD45.1+ using a BD
FACSAria Sorter. 105 sorted memory cells/well were cultured
in T cell complete medium (RPMI 1640 [BioConcept], 2 mM
L-glutamine [BioConcept], 2% penicillin/streptomycin [Sigma-
Aldrich], 10% FCS [Gibco], 25 mM HEPES [Pan Biotech], 1×
nonessential amino acids [Sigma], 50 µM β-mercaptoethanol
[Gibco], 1 mM sodium pyruvate [Gibco]) round-bottom 96-well
plates. Cells were cultured in the presence of 100 ng/ml IL-7
(eBioscience) and 100 ng/ml IL-15 (eBioscience). Memory by-
standers were either exposed to medium only or 0.25 µg/ml,
0.5 µg/ml, or 1 µg/ml of rIL-6 for 3 d or 6 h (recombinant mouse
IL-6 [carrier-free]; BioLegend).
Immunohistochemistry and ﬂuorescence microscopy
7-µm thin sections were prepared from frozen spleens em-
bedded in optimal cutting temperature compound (Sakura).
These sections were air-dried and afterwards ﬁxed in 4% PFA
for 30 min at RT. After a washing step, sections were incu-
bated with blocking buffer (PBS + 10% FCS) for 1 h at RT.
Staining was performed with the following antibodies (di-
luted 1:100 in PBS with 1% FCS, B220 was diluted 1:50) for 1 h
at RT in the dark: anti-podoplanin (8.1.1), anti-CD45.1 (A20),
anti-B220 (RA3-6B2), and anti-CD3 (17A2). Afterwards, slides
were washed twice with PBS and once with water, followed by
mounting with Mowiol (Sigma-Aldrich). 20–30 Z-stacks
(1 µm) were acquired with a Visitron Confocal System (in-
verse confocal microscope; Visitron Systems GmbH) with 10×
magniﬁcation (10× objective; type: Plan-Neoﬂuar; aperture:
0.3; immersion: air; contrast: Ph1) at RT. Acquisition of ﬂuo-
rescence pictures was performed using Evolve 512 EMCCD
cameras (Photometrics). Data were analyzed using Volocity
software (version 6.3; PerkinElmer).
Illumina sequencing
After sorting, the cells were resuspended and frozen in TRI
Reagent (Zymo Research). RNA was isolated using the Zymo
Research Direct-zol RNA MicroPrep (R2060) according to the
manufacturer’s protocol. RNA-seq libraries were prepared using
the SMARTer Stranded Total RNA-Seq Kit for Pico Input
Mammalian from Clonetech. Brieﬂy, total RNA samples (0.25–
10 ng) were reverse-transcribed using random priming into
double-stranded cDNA in the presence of a template switch oligo
(TSO). When the reverse transcription reaches the 59 end of the
RNA fragment, the enzyme’s terminal transferase activity adds
nontemplated nucleotides to the 39 end of the cDNA. The TSO
pairs with the added nontemplated nucleotide, enabling the
reverse transcription to continue replicating to the end of the
oligonucleotide. This results in a cDNA fragment that contains
sequences derived from the random priming oligo and the TSO.
PCR ampliﬁcation using primers binding to these sequences can
now be performed. The PCR adds full-length Illumina adapters,
including the index for multiplexing. Adapter sequences are
shown in Table S1. Ribosomal cDNA is cleaved by ZapR in the
presence of the mammalian-speciﬁc R-Probes. Remaining frag-
ments are enriched with a second round of PCR ampliﬁcation
using primers designed to match Illumina adapters. The quality
and quantity of the enriched libraries were validated using
Qubit (1.0) Fluorometer and the Tapestation (Agilent). The
product is a smear with an average fragment size of ∼360 bp.
The libraries were normalized to 10 nM in Tris-Cl 10 mM, pH
8.5, with 0.1% Tween 20.
The TruSeq SR Cluster Kit v4-cBot-HS or TruSeq PE Cluster
Kit v4-cBot-HS (Illumina, Inc.) was used for cluster generation
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using 8 pM of pooled normalized libraries on the cBOT. The li-
braries were sequenced on the Illumina HiSeq 2500 paired end
at 2 × 126 bp or single end 126 bp using the TruSeq SBS Kit v4-HS
(Illumina, Inc.). Read-alignment was performed using STAR
(v2.5.3a) using the reference genome GRCm38.p5 and with the
genome annotations from Ensembl (release 89). Gene expres-
sion values were computed using the function featureCounts
from the R package Rsubread (v1.26.0) with the minimum
quality mapping score set to 10 and the minimum feature
overlap parameter set to 10 bp. Differential expression was
computed using the generalized linear model implemented in
the Bioconductor package EdgeR (v3.18.1) using trimmed mean
of M values (TMM) as a normalization method.
RNA-seq data have been deposited in the ArrayExpress da-
tabase at EMBL-EBI under accession no. E-MTAB-7594.
Statistical analysis
Statistical signiﬁcance was determined as indicated by two-
tailed Student's t test using GraphPad Prism. Statistical signiﬁ-
cance was determined with *, P < 0.05, **, P < 0.01, ***, P < 0.001,
****, P < 0.0001.
Online supplemental material
Fig. S1 shows the numeric reduction of bystander memory
OT-I CD8+ T cells upon MCMV infection, quantiﬁcation of
bystander memory OT-I CD8+ T cells upon acute or chronic
LCMV infection, longitudinal quantiﬁcation of bystander
memory OT-I CD8+ T cells upon chronic LCMV infection,
quantiﬁcation of bystander memory OT-I CD8+ T cells upon
chronic LCMV infection in the presence or absence of NK
cells, and quantiﬁcation of memory OT-I CD8+ T cells in the
presence or absence of LCMV-speciﬁc effector CD8+ T cells.
Fig. S2 shows that OT-I CD8+ T cells do not recognize LCMV-
derived antigens, phenotypic alterations of memory by-
stander OT-I CD8+ T cells upon exposure to acute or chronic
LCMV infection, cytokine production by memory bystander
OT-I CD8+ T cells in lung and quantiﬁcation of memory by-
stander OT-I CD8+ T cells in spleen and lung, phenotypic al-
terations of memory bystander Rag1−/− OT-I CD8+ T cells in
spleen and lung upon chronic LCMV infection, PD-1 expres-
sion on memory bystander T cells in the spleen and in the
lung, and PD-1 CD39 coexpression on memory bystander
T cells in the spleen and in the lung. Fig. S3 shows RNA-seq
analysis of memory bystander OT-I CD8+ T cells in the pres-
ence or absence of chronic LCMV infection. Fig. S4 shows
ex vivo pSTAT1 expression in memory bystander OT-I CD8+
T cells, quantiﬁcation and pSTAT1 expression of memory
bystander OT-I CD8+ T cells upon IFNAR blockade, serum
cytokine levels, phenotypic and numeric alterations of
memory bystander OT-I CD8+ T cells upon chronic LCMV
infection and IFNAR blockade, phenotypic and numeric al-
terations of memory bystander OT-I CD8+ T cells upon
chronic LCMV infection and cytokine blockade, and numeric
alterations of memory bystander OT-I CD8+ T cells upon
chronic LCMV infection and IL-6R blockade. Fig. S5 shows
IL-6R expression on memory bystander OT-I CD8+ T cells.
Table S1 shows adapter sequences for Illumina sequencing.
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Figure S1. Numeric changes of bystander memory OT-I CD8+ T cells. (A)Numeric reduction of bystander memory OT-I CD8+ T cells upon MCMV infection.
Left: Experimental approach. Adoptive transfer of OT-I CD8+ T cells into congenic CD45.2+ WT C57BL/6 mice, followed by priming with VV-OVA. On day 30
after priming, the mice were infected with MCMV. The experiment was terminated 30 d after MCMV infection. Right: Total cell counts of OT-I memory
bystander CD8+ T cells in spleen, lung, and blood of memory only (white, uninfected) andmemory +MCMV (gray). (B)Quantiﬁcation of bystander memory OT-I
CD8+ T cells upon acute or chronic LCMV infection. Left: Experimental approach. Adoptive transfer of CD45.1+ OT-I CD8+ T cells into congenic CD45.2+ WT
C57BL/6 mice, followed by priming with VV-OVA. On day 30 after priming, the mice were infected with LCMV docile to induce chronic virus infection or with
LCMVWE in order to induce an acute infection. The experiment was terminated 30 d after LCMV infection. Right: Total cell counts of OT-I memory bystander
CD8+ T cells in spleen and lung of memory only (black, uninfected), memory + LCMV acute (gray), and memory + LCMV chronic (white). (C) Longitudinal
quantiﬁcation of bystander memory OT-I CD8+ T cells upon chronic LCMV infection. Left: Experimental approach. Adoptive transfer of 5 × 105 memory CD45.1+
OT-I CD8+ T cells into congenic CD45.2+ WT C57BL/6 mice. 1 d after adoptive transfer, mice were infected with 2 × 106 ffu LCMV. Mice were sacriﬁced on day
0, 1, 3, 5, 7, and 15 after infection comparing memory only with memory + LCMV. Right: Quantiﬁcation of the ratio of memory bystanders (memory) to memory
bystanders exposed to LCMV infection (memory + LCMV) over time in the spleen. (D) Quantiﬁcation of bystander memory OT-I CD8+ T cells upon chronic
LCMV infection in the presence or absence of NK cells. Left: Experimental setup. Memory bystander CD8+ T cells have been transferred to three groups of naive
B6 mice. One group remained untreated for 7 d (top), one group was chronically infected with LCMV docile for 7 d, and one group was injected with and
αNK1.1-depleting antibody every second day with the onset of chronic LCMV infection until 7 d after infection (right). Quantiﬁcation of total numbers of
memory bystander T cells from different groups in the spleen 7 d after infection. Memory bystanders only (black) compared with memory + LCMV (light gray)
and memory + LCMV + αNK1.1-depleting antibody (dark gray). (E) Quantiﬁcation of memory OT-I CD8+ T cells in the presence or absence of LCMV-speciﬁc
effector CD8+ T cells. Left: Experimental setup. Memory bystander CD8+ T cells were transferred to two groups of naive B6 mice. One group was injected with
5 × 106 endogenous CD8 T cells from day 7 LCMV-WE–infected donors (top); one group was injected with 5 × 106 endogenous CD8+ T cells from naive donors
(bottom). Right: Quantiﬁcation of total numbers of memory bystander T cells from different groups in the spleen and lung 7 d after transfer. Memory by-
standers + CD8+ T cells from naive mice (black) compared with memory + CD8+ T cells from day 7 LCMV-WE infected mice (gray). (A–E) One representative
experiment of twowith three to ﬁve mice per group. Statistical analysis was performed using the unpaired two-tailed Student`s t test: ns, P ≥ 0.05; *, P < 0.05;
**, P < 0.01; ****, P < 0.0001. Error bars show SEM.
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Figure S2. Phenotypic and functional changes of bystander memory OT-I CD8+ T cells. (A) OT-I CD8+ T cells do not recognize LCMV-derived antigens.
Representative ﬂow cytometry plots showing the expression of CD44 versus cell proliferation dye (CPD; as a proxy for T cell proliferation) for TCR transgenic
P14 or OT-I CD8+ T cells in the presence or absence of dendritic cells (DCs) with or without LCMV docile infection (MOI 0.5). TCR transgenic T cells were
cultured in the presence of cognate peptide (GP33–41 for P14 and SIINFEKL for OT-I T cells) as positive controls. Parameters were measured 3 d after co-culture.
One representative experiment out of two is shown with duplicates per group. (B) Phenotypic alterations of memory bystander OT-I CD8+ T cells upon
exposure to acute or chronic LCMV infection. Adoptive transfer of CD45.1+ OT-I CD8+ T cells into congenic CD45.2+ WT C57BL/6 mice, followed by priming
with VV-OVA. On day 30 after priming, the mice were infected with LCMV docile to induce chronic virus infection or with LCMVWE in order to induce an acute
infection. The experiment was terminated 30 d after LCMV infection. Memory bystander OT-I CD8+ T cells in the spleen and in the lung. Quantiﬁcation of
percentages of KLRG1+ IL-7Rα− OT-I T cells and KLRG1− IL-7Rα+ OT-I T cells shown for memory only (white, uninfected), memory + LCMV acute (gray), and
+ LCMV (black) in the spleen and lung. One representative experiment out of two is shown with four mice per group. (C) Cytokine production by memory
bystander OT-I CD8+ T cells in lung and quantiﬁcation of memory bystander OT-I CD8+ T cells in spleen and lung. Mice were persistently infected with LCMV
docile. 30 d after infection CD45.1+ OT-I memory CD8+ T cells were transferred into these mice. The experiment was terminated 30 d after transfer. Left:
Quantiﬁcation of IFNγ, IL-2, and TNFα produced by memory bystanders from memory only (white, uninfected) and + LCMV (black) in the lung after 6 h of
restimulation with the cognate antigen. Right: Quantiﬁcation of total numbers recovered 30 d after transfer from the spleen and the lung comparing memory
bystanders from memory only (white, uninfected) and + LCMV (black). One representative experiment out of two is shown with four mice per group. (D)
Phenotypic alterations of memory bystander Rag1−/− OT-I CD8+ T cells in spleen and lung upon chronic LCMV infection. Adoptive transfer of CD45.1+ OT-I
Rag1−/− CD8+ T cells into congenic CD45.2+ WT C57BL/6 mice, followed by priming with VV-OVA. On day 30 after priming, the mice were persistently infected
with LCMV docile. The experiment was terminated 30 d after LCMV infection. Memory bystander OT-I CD8+ T cells in the spleen and in the lung. Quantiﬁcation
of percentages of KLRG1+ IL-7Rα− Rag1−/− OT-I T cells and KLRG1− IL-7Rα+ Rag1−/− OT-I T cells shown for memory only (white, uninfected) and + LCMV (black)
in the spleen and lung. One representative experiment out of two is shown with four mice per group. (E) PD-1 expression on memory bystander T cells in the
spleen and in the lung. Left: Shown are ﬂow cytometry plots pregated on live CD8+ CD45+ OT-I T cells. Representative FACS plots of memory only (white,
uninfected) and memory + LCMV chronic (black) and memory + LCMV acute (gray) for their expression of PD-1. Right: Quantiﬁcation of percentages of PD-1+
OT-I T cells shown for memory only (white, uninfected), memory + LCMV chronic (black), and memory + LCMV acute (gray) in the spleen and lung. FSC-H,
forward scatter height. (F) PD-1 CD39 coexpression on memory bystander T cells in the spleen and in the lung. Left: Representative FACS plots of memory only
(white, uninfected). memory + LCMV chronic (black), and memory + LCMV acute (gray) for their coexpression of PD-1 and CD39. Right: Quantiﬁcation of
percentages of PD-1+ CD39+ OT-I T cells shown for memory only (white, uninfected) and memory + LCMV chronic (black) and memory + LCMV acute (gray) in
the spleen and lung. One representative experiment out of two is shown with four mice per group. (A–F) Statistical analysis was performed using the unpaired
two-tailed Student’s t test: ns, P ≥ 0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Error bars show SEM.
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Figure S3. RNA-seq analysis of memory bystander OT-I CD8+ T cells in the presence or absence of chronic LCMV infection. (A and B) Heat maps
depicting fragments per kilobase million values scaled by row are shown for genes of either the TCR signaling pathway (A) or IFN-simulated genes (B).
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Figure S4. Role of cytokines for phenotypic and numeric alterations of memory bystander OT-I CD8+ T cells. (A) Ex vivo pSTAT1 expression in memory
bystander OT-I CD8+ T cells. Representative histogram of CD45.1+ CD8+ memory OT-I T cells that had been exposed to LCMV infection for 30 d. The histogram
and quantiﬁcation in percentage show pSTAT1 on memory bystander T cells under cleared (+ LCMV cleared, black) and under still viremic (+ LCMV viremic,
white) conditions. (B) Quantiﬁcation and pSTAT1 expression of memory bystander OT-I CD8+ T cells upon IFNAR blockade. Quantiﬁcation of percentage of
pSTAT1 (left) or total numbers (right) after 30 d after LCMV infection (memory + LCMV, white) compared with uninfected (memory only, black) control as well
as αIFNAR blocking with the onset of LCMV infection (memory + LCMV + αIFNAR, white with black dots). One representative experiment out of two is shown
with four mice per group. (C) Serum cytokine levels. Cytokine levels of IL-6, IFNγ, and TNF in the spleen and lung over 30 d of infection (LCMV, squares, no
ﬁlling) and naive controls (naive, circle, gray ﬁlling), measured by CBA. (D) Phenotypic and numeric alterations of memory bystander OT-I CD8+ T cells upon
chronic LCMV infection and IFNAR blockade. Left: Experimental approach. Adoptive transfer of CD45.1+ OT-I CD8+ T cells into congenic CD45.2+ WT C57BL/6
mice, followed by priming with VV-OVA. On day 30 after priming, the mice were persistently infected with LCMV docile. With the onset of the infection, 500 µg
of αIFNAR blocking antibody was injected i.p. every second day. The experiment was terminated 15 d after LCMV infection. Middle: Quantiﬁcation of per-
centages of KLRG1+ IL-7Rα− OT-I T cells and KLRG1− IL-7Rα+ OT-I T cells shown for memory only (black, uninfected), memory + LCMV (white), and LCMV+
αIFNAR (white with black dots) in the spleen and lung. Right: Quantiﬁcation of total numbers shown for memory only (black, uninfected), memory + LCMV
(white), and LCMV+ αIFNAR (white with black dots) in the spleen and lung. (E) Phenotypic and numeric alterations of memory bystander OT-I CD8+ T cells
upon chronic LCMV infection and cytokine blockade. Left: Experimental approach. Adoptive transfer of CD45.1+ OT-I CD8+ T cells into congenic CD45.2+ WT
C57BL/6 mice, followed by priming with VV-OVA. On day 30 after priming, the mice were persistently infected with LCMV docile. With the onset of the
infection, αIL-2, αIL-7, or αIFNγ blocking antibody was injected i.p. every third day. The experiment was terminated 7 d after LCMV infection. Middle:
Quantiﬁcation of percentages of KLRG1+ IL-7Rα− OT-I T cells and KLRG1− IL-7Rα+ OT-I T cells is shown for memory only (black), LCMV + PBS (white), LCMV +
αIL-2 (white with black dots), LCMV + αIL-7 (white with angled stripes), and LCMV + αIFNγ (white with horizontal stripes) in the spleen and lung. Right:
Quantiﬁcation of total numbers of OT-I T cells shown for memory only (black), LCMV + PBS (white), LCMV + αIL-2 (white with black dots), LCMV + αIL-7 (white
with angled stripes), and LCMV + αIFNγ (white with horizontal stripes) in the spleen and lung. (F) Numeric alterations of memory bystander OT-I CD8+ T cells
upon chronic LCMV infection and IL-6R blockade. Left: Experimental approach. Adoptive transfer of CD45.1+ OT-I CD8+ T cells into congenic CD45.2+ WT
C57BL/6 mice, followed by priming with VV-OVA. On day 30 after priming, the mice were persistently infected with LCMV docile. With the onset of the
infection, αIL-6R blocking antibody was injected i.p. every second day. The experiment was terminated 14 d after LCMV infection. Right: Quantiﬁcation of total
numbers of OT-I T cells shown for uninfected control mice (white), LCMV-infected mice (black), and LCMV + αIL-6R mice (gray) in the spleen and lung. (A–F)
One representative experiment of two with three to ﬁve mice per group. Statistical analysis was performed using the unpaired two-tailed Student’s t test: ns, P
≥ 0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Error bars show SEM.
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Figure S5. IL-6R expression on memory bystander OT-I CD8+ T cells. (A) Experimental approach. Adoptive transfer of CD45.1+ OT-I CD8+ T cells into
congenic CD45.2 WT C57BL/6 mice, followed by priming with VV-OVA. On day 30 after priming, mice were persistently infected with LCMV docile. The
experiment was terminated 30 d after LCMV infection. (B) Left: Representative ﬂow cytometry plots of the expression of KLRG1 and IL-6Rα on memory only
(white) and memory + LCMV (block). Right: Quantiﬁcation of percentages of KLRG1+ IL-6Rα+ OT-I T cells shown for memory only (white, uninfected) and
memory + LCMV (black) in the spleen. Error bars show SEM. (C) Representative ﬂow cytometry plots of the expression of IL-6Rα of memory only (left) and
memory + LCMV (right). Gates are drawn according to low and high expression of IL-7Rα and in the following the expression of IL-6Rα is shown for the
respective gates (bottom). FSC-H, forward scatter height. One representative experiment out of two is shown with three to ﬁve mice per group. Statistical
analysis was performed using the unpaired two-tailed Student`s t test: *, P < 0.05; **, P < 0.01.
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Table S1. Adapter sequences for Illumina sequencing.
Adapter sequences
i7 index i5 index
R1 ATTACTCG F1 TATAGCCT
R2 TCCGGAGA F2 ATAGAGGC
R3 CGCTCATT F3 CCTATCCT
R4 GAGATTCC F4 GGCTCTGA
R5 ATTCAGAA F5 AGGCGAAG
R6 GAATTCGT F6 TAATCTTA
R7 CTGAAGCT F7 CAGGACGT
R8 TAATGCGC F8 GTACTGAC
R9 CGGCTATG
R10 TCCGCGAA
R11 TCTCGCGC
R12 AGCGATAG
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